-
Repotrectinib, sold
under the
brand name Augtyro, is an anti-cancer
medication used for the
treatment of non-small cell lung cancer. It is
taken by mouth...
- (INN)
Repan reparixin (USAN)
Repatha repifermin (INN)
repirinast (INN)
repotrectinib (INN)
repromicin (INN)
Repronex reproterol (INN)
Requip Resa Resaid...
- price),
helping to
boost its
complement of
cancer drugs,
specifically repotrectinib. That same month, the
company announced it
would be
investing $180m...
- Infigratinib,
Larotrectinib (NTRK),
Pemigatinib (FGFR), Pralsetinib,
Repotrectinib (ROS1, TRK, ALK),
Selpercatinib (VEGFR, FGFR),
Vandetanib (VEGFR, EGFR)...
- L01EX25
Umbralisib L01EX26
Sitravatinib L01EX27
Capivasertib L01EX28
Repotrectinib QL01EX90
Toceranib L01FA01
Rituximab L01FA02
Ofatumumab L01FA03 Obinutuzumab...
- for
treatment of TrkA-, TrkB-, TrkC-, ROS1- and ALK-positive NSCLC)
Repotrectinib (TPX-0005,
Turning Point Therapeutics)
Belizatinib (TSR-011, Tesaro)...
-
deletions or exon 21 L858R mutations, as
detected by an FDA-approved test
Repotrectinib Treatment of
people aged
twelve years of age and
older with
solid tumors...
- Infigratinib,
Larotrectinib (NTRK),
Pemigatinib (FGFR), Pralsetinib,
Repotrectinib (ROS1, TRK, ALK),
Selpercatinib (VEGFR, FGFR),
Vandetanib (VEGFR, EGFR)...
